Long-term harmful effects of BPA exposure: Cereplast lauds FDA's demand for additional study

Cereplast, Inc. (OTCBB:CERP), manufacturer of proprietary bio-based sustainable plastics, applauds the Food and Drug Administration (FDA) for demanding increased study of the long-term effects of Bisphenol A (BPA) exposure.

“The increased level of safety, coupled with the fact that bioplastics are renewable and eco-friendly means less potential for opposition in regards to their expanded use, especially in applications such as toys, food service ware, infant furniture, etc.”

BPA is a manufacturing chemical employed mainly in the production of clear and hard plastics known as "polycarbonate” and is found in a great number of consumer products including baby bottles and recyclable water bottles. It is also used in epoxy resins, a thermosetting resin, which is used as a protective lining on the inner side of beverage cans and metal-based food tins.

“After a multitude of research, the FDA expressed concern regarding the potential harmful effects of BPA and the increased risks of cancer for humans -- reversing the agency's controversial 2008 ruling,” said Frederic Scheer, Founder, Chairman and CEO of Cereplast, Inc.

After the repeated urging of consumer and watchdog groups at the end of the past decade, the FDA, which initially approved the use of BPA as a food contact subject or indirect food additive in the late 1960s, began reinvestigating the chemical’s use in products that come in contact with food. As part of its recent statement, the FDA called for additional BPA studies by both government and non-government organizations and also announced a set of studies by its own National Center for Toxicological Research focusing on the safety of low doses of BPA.

“While even the most recent studies documenting the effects of BPA on humans are largely inconclusive and the FDA has made no moves of yet to ban the substance in plastics, bioplastics provide the safe alternative. Bioplastics firms like Cereplast are offering BPA-free alternatives and finding ourselves in greater favor among consumers and manufacturers,” said Scheer. “The increased level of safety, coupled with the fact that bioplastics are renewable and eco-friendly means less potential for opposition in regards to their expanded use, especially in applications such as toys, food service ware, infant furniture, etc.”

In the interim, the U.S. Department of Health and Human Services has released recommended ways for the public to reduce their exposure to BPA at http://www.hhs.gov/safety/bpa.

Cereplast offers two families of resins: Cereplast Compostables® are renewable, ecologically sound substitutes for petroleum-based plastic products that replace nearly 100% of the petroleum-based additives used in traditional plastics with bio-based material such as corn, wheat, tapioca and potato starches. Cereplast Compostables® are a proprietary and patented formulation from Cereplast using Ingeo® biopolymers from NatureWorks. Cereplast Hybrids® are resins consisting of traditional polyolefins with up-to 50% renewable content. Cereplast recently announced the launch of an Algae Plastic that will substitute agricultural feedstock with algae as soon as 2011.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk